10.25384/SAGE.9205514.v1
David Crawford
David
Crawford
Mitchell Friedman
Mitchell
Friedman
Supplemental Material, DS5_IJT_10.1177_1091581819864105 - Evaluation of the Developmental Toxicity of Vedolizumab, an α<sub>4</sub>β<sub>7</sub> Receptor Antagonist, in Rabbit and Nonhuman Primate
SAGE Journals
2019
preclinical
pregnancy
monoclonal antibody
placental transfer
2019-08-01 12:12:54
Journal contribution
https://sage.figshare.com/articles/journal_contribution/Supplemental_Material_DS5_IJT_10_1177_1091581819864105_-_Evaluation_of_the_Developmental_Toxicity_of_Vedolizumab_an_sub_4_sub_sub_7_sub_Receptor_Antagonist_in_Rabbit_and_Nonhuman_Primate/9205514
<p>Supplemental Material, DS5_IJT_10.1177_1091581819864105 for Evaluation of the Developmental Toxicity of Vedolizumab, an α<sub>4</sub>β<sub>7</sub> Receptor Antagonist, in Rabbit and Nonhuman Primate by David Crawford and Mitchell Friedman in International Journal of Toxicology</p>